ArticleTherapeutic advances in medical oncology2021

Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.

Moritz Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.